NI vs SPRO · P/E 23, rev $3.61B vs P/E 9.6, rev $258.0K
NiSource Inc (NI) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
NiSource Inc (NI) is a utilities - regulated gas company listed on NYSE.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported NI revenue for 2026-06-30 was $3.61B. Net income was $552.6M. Revenue was up 55.5% from 2026-03-31 to 2026-06-30. NI currently screens at market cap $22.42B and trailing P/E 23.3.
Latest reported SPRO revenue for 2026-06-30 was $258.0K. Net income was -$16.8M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
NI currently screens at market cap $22.42B and trailing P/E 23.3. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the NI and SPRO stock pages for the full models.
Not investment advice.